| Entry |
|
|---|
| Symbol |
PPP3CA
|
|---|
| Name |
(RefSeq) protein phosphatase 3 catalytic subunit alpha
|
|---|
| KO |
| K04348 | serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16] |
|
|---|
| Organism |
csab Chlorocebus sabaeus (green monkey)
|
|---|
| Pathway |
| csab04625 | C-type lectin receptor signaling pathway |
| csab04650 | Natural killer cell mediated cytotoxicity |
| csab05022 | Pathways of neurodegeneration - multiple diseases |
| csab05166 | Human T-cell leukemia virus 1 infection |
| csab05167 | Kaposi sarcoma-associated herpesvirus infection |
| csab05170 | Human immunodeficiency virus 1 infection |
| csab05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
|---|
| Brite |
KEGG Orthology (KO) [BR:csab00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
103236040 (PPP3CA)
04310 Wnt signaling pathway
103236040 (PPP3CA)
04370 VEGF signaling pathway
103236040 (PPP3CA)
04020 Calcium signaling pathway
103236040 (PPP3CA)
04022 cGMP-PKG signaling pathway
103236040 (PPP3CA)
09140 Cellular Processes
09143 Cell growth and death
04114 Oocyte meiosis
103236040 (PPP3CA)
04218 Cellular senescence
103236040 (PPP3CA)
09150 Organismal Systems
09151 Immune system
04625 C-type lectin receptor signaling pathway
103236040 (PPP3CA)
04650 Natural killer cell mediated cytotoxicity
103236040 (PPP3CA)
04660 T cell receptor signaling pathway
103236040 (PPP3CA)
04658 Th1 and Th2 cell differentiation
103236040 (PPP3CA)
04659 Th17 cell differentiation
103236040 (PPP3CA)
04662 B cell receptor signaling pathway
103236040 (PPP3CA)
09152 Endocrine system
04922 Glucagon signaling pathway
103236040 (PPP3CA)
04921 Oxytocin signaling pathway
103236040 (PPP3CA)
04924 Renin secretion
103236040 (PPP3CA)
09156 Nervous system
04724 Glutamatergic synapse
103236040 (PPP3CA)
04728 Dopaminergic synapse
103236040 (PPP3CA)
04720 Long-term potentiation
103236040 (PPP3CA)
09158 Development and regeneration
04360 Axon guidance
103236040 (PPP3CA)
04380 Osteoclast differentiation
103236040 (PPP3CA)
09160 Human Diseases
09161 Cancer: overview
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
103236040 (PPP3CA)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
103236040 (PPP3CA)
05170 Human immunodeficiency virus 1 infection
103236040 (PPP3CA)
05163 Human cytomegalovirus infection
103236040 (PPP3CA)
05167 Kaposi sarcoma-associated herpesvirus infection
103236040 (PPP3CA)
09171 Infectious disease: bacterial
05152 Tuberculosis
103236040 (PPP3CA)
09164 Neurodegenerative disease
05010 Alzheimer disease
103236040 (PPP3CA)
05014 Amyotrophic lateral sclerosis
103236040 (PPP3CA)
05020 Prion disease
103236040 (PPP3CA)
05022 Pathways of neurodegeneration - multiple diseases
103236040 (PPP3CA)
09165 Substance dependence
05031 Amphetamine addiction
103236040 (PPP3CA)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
103236040 (PPP3CA)
09180 Brite Hierarchies
09181 Protein families: metabolism
01009 Protein phosphatases and associated proteins [BR:csab01009]
103236040 (PPP3CA)
Enzymes [BR:csab01000]
3. Hydrolases
3.1 Acting on ester bonds
3.1.3 Phosphoric-monoester hydrolases
3.1.3.16 protein-serine/threonine phosphatase
103236040 (PPP3CA)
Protein phosphatases and associated proteins [BR:csab01009]
Protein serine/threonine phosphatases
Phosphoprotein phosphatases (PPPs)
Calcineurin (PPP3/ PP2B)
Catalytic subunits
103236040 (PPP3CA)
|
|---|
| SSDB |
|
|---|
| Motif |
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| Position |
7:complement(49149044..49478796)
|
|---|
| AA seq |
521 aa
MSEPKAIDPKLSTTDRVVKAVPFPPSHRLTAKEVFDNDGKPRVDILKAHLMKEGRLEESV
ALRIITEGASILRQEKNLLDIDAPVTVCGDIHGQFFDLMKLFEVGGSPANTRYLFLGDYV
DRGYFSIECVLYLWALKILYPKTLFLLRGNHECRHLTEYFTFKQECKIKYSERVYDACMD
AFDCLPLAALMNQQFLCVHGGLSPEINTLDDIRKLDRFKEPPAYGPMCDILWSDPLEDFG
NEKTQEHFTHNTVRGCSYFYSYPAVCEFLQHNNLLSILRAHEAQDAGYRMYRKSQTTGFP
SLITIFSAPNYLDVYNNKAAVLKYENNVMNIRQFNCSPHPYWLPNFMDVFTWSLPFVGEK
VTEMLVNVLNICSDDELGSEEDGFDGATAAARKEVIRNKIRAIGKMARVFSVLREESESV
LTLKGLTPTGMLPSGVLSGGKQTLQSATVEAIEADEAIKGFSPQHKITSFEEAKGLDRIN
ERMPPRRDAMPSDANLNSINKALTSETNGTDSNGSNSSNIQ |
|---|
| NT seq |
1566 nt +upstreamnt +downstreamnt
atgtccgagcctaaggcaattgatcccaagttgtcgacgaccgacagggtggtgaaagct
gttccatttcctccaagtcaccggcttacagcaaaagaagtgtttgataatgatggaaaa
cctcgtgtggatatcttaaaggcacatcttatgaaggagggaagactggaagagagtgtt
gcattgagaataataacagagggtgcatcaattcttcgacaggaaaaaaacttgctggat
attgatgcgccagtcacagtttgtggggacattcatggacaattctttgacttgatgaag
ctctttgaagtcgggggatctcctgccaacactcgctacctcttcttaggggactatgtt
gacagagggtacttcagtatcgaatgtgtgctgtatttgtgggccttgaaaattctttac
cccaaaacactgtttttactccgtggaaatcatgaatgtagacatctaacagagtatttc
acatttaaacaagaatgtaaaataaagtattcagaacgcgtatatgatgcctgtatggat
gcctttgactgccttcccttggctgccctgatgaaccagcagttcctgtgtgtacatggt
ggcttgtctccagagattaacaccttagatgatatcagaaaattagaccgattcaaagaa
ccacctgcatatggacctatgtgtgatatcctgtggtcagaccccctggaagattttgga
aatgagaagactcaggaacatttcactcacaacacagtcagggggtgttcgtacttctac
agttacccggctgtatgtgaattcttacagcacaataacttgttatctatacttcgagcc
catgaagcccaagatgcagggtaccgcatgtacaggaaaagccaaacaacagggttccct
tctctaattacaattttttcagcaccaaattacttagatgtatacaataacaaagctgca
gtattgaagtatgagaacaatgttatgaatatcaggcaattcaactgttctcctcatcca
tactggcttccaaatttcatggatgtttttacttggtccctgccttttgttggggaaaaa
gtgactgagatgctggtaaatgtcctcaacatctgctctgatgatgaactagggtcagaa
gaagatggatttgatggtgcaacagctgcagcccggaaggaggtgataaggaacaagatc
cgagcaataggcaaaatggccagagtgttctcagtgctcagagaagagagtgagagtgtg
ctgacgctgaaaggcttgaccccgactggcatgctccccagcggagtactttctggaggg
aagcaaaccctacaaagcgctactgttgaggctattgaggctgatgaagctatcaaagga
ttttcaccacaacataagatcactagcttcgaggaagccaagggcttagaccgaattaat
gagaggatgccgcctcgcagagatgccatgccctctgacgccaaccttaactccatcaac
aaggctctcacctcagagactaacggcacggacagcaatggcagtaatagcagcaatatt
cagtga |
|---|
